Published on June 13, 2016

Indian pharmaceutical market nurtured 7.7 per cent in the month of May compared with 3.5 per cent in April. However the Indian pharmaceuticals market's growth this May has been the lowest in two years, impacted by a drop in sales of fixed dose combination drugs, fresh price cuts and a lower-than-expected uptake.

For May, the pharmaceuticals market grew by 7.7% compared to 11.6% during the same month last year, as per market source.

Recently Indian drug makers more affected by the drop in volumes in FDCs than multinational drug makers in the country. As per the report the country's FDC market dropped around14.6% .

Recently most key players underperformed the pharmaceutical market growth but saw improvement in compare to April. Indian players and MNCs reported a moderate growth of 7.9 per cent and 7 per cent, respectively in May 2016.

Presently Telangana government decided to setting up of a 'Pharma City' on 12,500 acres of land in Rangareddy and Mahbubnagar districts of the state.

Moreover, Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows as it is impacting accessibility and growth of the generic industry in the country.